Transamerica Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1
Closed -$1K 872
2015
Q4
$1K Sell
1
-339
-100% -$101K ﹤0.01% 803
2015
Q3
$93K Buy
340
+44
+15% +$13.5K 0.01% 328
2015
Q2
$90K Buy
296
+218
+279% +$65K 0.01% 393
2015
Q1
$24K Sell
78
-1,981
-96% -$565K ﹤0.01% 520
2014
Q4
$530K Buy
2,059
+2,058
+205,800% +$514K 0.04% 178
2014
Q3
$1K Hold
1
﹤0.01% 671
2014
Q2
$1K Buy
+1
New +$207 ﹤0.01% 681
2013
Q4
Sell
-2
Closed -$1K 648
2013
Q3
$1K Sell
2
-375
-99% -$50K ﹤0.01% 587
2013
Q2
$48K Buy
+377
New +$42.7K 0.01% 280

Other funds holding AGN

Transamerica Financial Advisors's AGN Position: Q1 2016 in Review

Transamerica Financial Advisors sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 1 share — an estimated $1K sold.

Transamerica Financial Advisors first reported a position in AGN in Q2 2013 and held it in 9 quarters. The position peaked at $530K in Q4 2014. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Transamerica Financial Advisors reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Transamerica Financial Advisors sold 1 Allergan plc share in Q1 2016, an estimated $1K.
  • Transamerica Financial Advisors first reported a position in Allergan plc in Q2 2013 and held it in 9 quarters.
  • Transamerica Financial Advisors's Allergan plc position peaked at $530K in Q4 2014.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Transamerica Financial Advisors's 13F filing for Q1 2016, filed 21 Apr 2016.